The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(5-(4-(hydroxymethyl)piperidin-1-yl)-2-morpholinobenzo[d]thiazol-6-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide ID: ALA4474636
PubChem CID: 155537218
Max Phase: Preclinical
Molecular Formula: C24H27N7O3S
Molecular Weight: 493.59
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1cc2sc(N3CCOCC3)nc2cc1N1CCC(CO)CC1)c1cnn2cccnc12
Standard InChI: InChI=1S/C24H27N7O3S/c32-15-16-2-6-29(7-3-16)20-12-19-21(35-24(28-19)30-8-10-34-11-9-30)13-18(20)27-23(33)17-14-26-31-5-1-4-25-22(17)31/h1,4-5,12-14,16,32H,2-3,6-11,15H2,(H,27,33)
Standard InChI Key: OSATXCGVOWUMIG-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 40 0 0 0 0 0 0 0 0999 V2000
17.6276 -5.2671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3359 -4.8563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3311 -4.0342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6220 -3.6308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0363 -3.6213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0452 -5.2621 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0440 -6.0758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7493 -6.4816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4578 -6.0737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4566 -5.2556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7468 -4.8453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1655 -6.4823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8732 -6.0736 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0314 -2.8041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7366 -2.3912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3212 -2.3998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.6158 -1.4015 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8175 -1.5764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0287 -2.1068 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4875 -2.7144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7434 -3.4849 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5402 -3.6489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0806 -3.0363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8217 -2.2682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9191 -4.8601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9178 -4.0420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1394 -3.7903 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.6594 -4.4529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1414 -5.1140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8435 -4.4547 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4350 -3.7459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6214 -3.7452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2101 -4.4517 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6186 -5.1606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4384 -5.1629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 26 1 0
3 5 1 0
2 6 1 0
6 7 1 0
6 11 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
9 12 1 0
12 13 1 0
5 14 1 0
14 15 1 0
14 16 2 0
15 20 2 0
19 17 1 0
17 18 2 0
18 15 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
25 26 2 0
26 27 1 0
27 28 1 0
28 29 2 0
29 25 1 0
30 31 1 0
30 35 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
28 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 493.59Molecular Weight (Monoisotopic): 493.1896AlogP: 2.64#Rotatable Bonds: 5Polar Surface Area: 108.12Molecular Species: NEUTRALHBA: 10HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.24CX Basic pKa: 4.04CX LogP: 2.35CX LogD: 2.35Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.44Np Likeness Score: -2.31
References 1. Bryan MC, Drobnick J, Gobbi A, Kolesnikov A, Chen Y, Rajapaksa N, Ndubaku C, Feng J, Chang W, Francis R, Yu C, Choo EF, DeMent K, Ran Y, An L, Emson C, Huang Z, Sujatha-Bhaskar S, Brightbill H, DiPasquale A, Maher J, Wai J, McKenzie BS, Lupardus PJ, Zarrin AA, Kiefer JR.. (2019) Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors., 62 (13): [PMID:31082230 ] [10.1021/acs.jmedchem.9b00439 ]